• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS D-DIMER; FIBRIN SPLIT PRODUCTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS D-DIMER; FIBRIN SPLIT PRODUCTS Back to Search Results
Catalog Number 04912551190
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/24/2018
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).Unique identifier (udi)#: (b)(4).The patient was born in (b)(6).
 
Event Description
The customer stated that they received erroneous results for one patient sample tested for d-di tina-quant d-dimer gen.2 (ddi) on a cobas 6000 c (501) module - c501.The erroneous results were reported outside of the laboratory to a doctor.The sample initially resulted with a ddi value of 3.34 mg/l feu accompanied by a data flag.The sample was automatically repeated, resulting as 3.33 mg/l feu accompanied by a data flag.The patient was sent to the hospital based on the c501 value.At the hospital, the patient was tested for ddi using sysmex analyzer which used siemens reagent.The result from the sysmex analyzer was normal, so no treatment was provided.On (b)(6) 2018, the sample was repeated on the c501 analyzer, resulting as 3.31 mg/l feu accompanied by a data flag.The sample was automatically repeated, resulting as 3.33 mg/l feu accompanied by a data flag.The sample was sent to another laboratory where it was measured using the same type of analyzers.On a second c501 analyzer at the other site, the sample resulted as 3.58 mg/l feu.On a sysmex analyzer at the other site, the sample resulted with a value that was under the limit of detection.No adverse events were alleged to have occurred with the patient.The c501 analyzer serial number was (b)(4).
 
Manufacturer Narrative
A sample from the patient was provided for investigation.Investigations of the sample were able to duplicate the results obtained by the customer.A 1:5 dilution of the sample did not show linear dilution behavior, but the result was accompanied by a data flag which invalidated the result.The measurements did not indicate that an interfering factor was present.
 
Manufacturer Narrative
Upon review of the calibration data, frequent calibration failures were observed.Quality controls were within range on (b)(6) 2018.Quality control recovery was generally good.Abnormal probe aspiration alarms occurred on (b)(6) 2018.Reagent warning level alarms occurred on (b)(6) 2018.Further investigation of the sample showed decreasing ddi results when the sample was diluted.This indicates interference.The igm result was also above the normal range, which could indicate a gammopathy interference.Product labeling lists immunoglobulin interference as a potential limitation of the assay.Sample measurements did not indicate an interference by rheumatoid factors or fibrinogen.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
D-DIMER
Type of Device
FIBRIN SPLIT PRODUCTS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7507855
MDR Text Key108381369
Report Number1823260-2018-01459
Device Sequence Number1
Product Code GHH
Combination Product (y/n)N
PMA/PMN Number
K062203
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 07/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number04912551190
Device Lot Number290802
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 04/26/2018
Initial Date FDA Received05/11/2018
Supplement Dates Manufacturer Received04/26/2018
04/26/2018
Supplement Dates FDA Received07/12/2018
07/30/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CONTRACEPTIVE
Patient Age22 YR
-
-